BioMaxima S.A. (WSE:BMX)

Market Cap	51.16M -17.8%
Revenue (ttm)	59.11M +17.5%
Net Income	649.00K
EPS	0.15
Shares Out	4.19M
PE Ratio	81.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,907
Average Volume	4,089
Open	12.15
Previous Close	12.35
Day's Range	12.10 - 12.20
52-Week Range	10.70 - 15.65
Beta	0.23
RSI	38.03
Earnings Date	Apr 30, 2026

About BioMaxima

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in v...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 135
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: BMX

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.